We are live on ! Find out more
Natixis Advisors

Natixis Advisors Portfolio holdings

AUM $71.9B
1-Year Est. Return 28.03%
This Fund
S&P 500
This Quarter Est. Return
-3.85%
1 Year Est. Return
+28.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+131.42%
10 Year Est. Return
+475.22%
AUM
$23.6B
AUM Growth
+$900M
Cap. Flow
+$1.81B
Cap. Flow %
7.66%
Top 10 Hldgs %
15.31%
Holding
1,542
New
90
Increased
818
Reduced
532
Closed
102

Top Sells

Rank Stock Value
1
VTI icon
Vanguard Total Stock Market ETF
VTI
+$31.5M
2
NTR icon
Nutrien
NTR
+$29.5M
3
T icon
AT&T
T
+$28.9M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$27.6M
5
SNY icon
Sanofi
SNY
+$27.1M

Sector Composition

Rank Sector Weight
1 Technology 18.61%
2 Healthcare 14.15%
3 Financials 13.71%
4 Consumer Discretionary 9.67%
5 Industrials 9.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MMSI icon
901
Merit Medical Systems
MMSI
$4.82B
$1.95M 0.01%
34,560
+7,747
+29% +$446K
PRGO icon
902
Perrigo
PRGO
$1.44B
$1.95M 0.01%
54,707
-7,282
-12% -$293K
PBR icon
903
Petrobras
PBR
$120B
$1.94M 0.01%
157,244
+49,486
+46% +$655K
FSV icon
904
FirstService
FSV
$6.55B
$1.93M 0.01%
16,253
+1,673
+11% +$214K
BIDU icon
905
Baidu
BIDU
$35.7B
$1.93M 0.01%
16,438
-1,899
-10% -$259K
PENN icon
906
PENN Entertainment
PENN
$2.84B
$1.93M 0.01%
69,962
+31,291
+81% +$1.01M
THC icon
907
Tenet Healthcare
THC
$22.2B
$1.89M 0.01%
36,592
+21,048
+135% +$1.25M
KBR icon
908
KBR
KBR
$4.56B
$1.89M 0.01%
43,648
-5,447
-11% -$268K
VNT icon
909
Vontier
VNT
$4.54B
$1.85M 0.01%
110,928
-35,570
-24% -$793K
INCY icon
910
Incyte
INCY
$25.4B
$1.84M 0.01%
27,635
-4,029
-13% -$298K
KAI icon
911
Kadant
KAI
$3.58B
$1.83M 0.01%
10,997
-51
-0.5% -$9.49K
DINO icon
912
HF Sinclair
DINO
$16.2B
$1.83M 0.01%
34,034
+3,914
+13% +$194K
BPOP icon
913
Popular Inc
BPOP
$11B
$1.83M 0.01%
25,404
-336
-1% -$26.1K
HRI icon
914
Herc Holdings
HRI
$4.78B
$1.83M 0.01%
17,622
-624
-3% -$69.4K
INFY icon
915
Infosys
INFY
$51B
$1.83M 0.01%
107,780
-1,210
-1% -$22.6K
UCTT
916
Ultra Clean Holdings
UCTT
$3.12B
$1.83M 0.01%
71,040
-39,131
-36% -$1.2M
CRI icon
917
Carter's
CRI
$1.43B
$1.83M 0.01%
27,896
+2,414
+9% +$185K
IEF icon
918
iShares 7-10 Year Treasury Bond ETF
IEF
$47.2B
$1.82M 0.01%
+19,000
New +$1.93M
ORAN
919
DELISTED
Orange
ORAN
$1.81M 0.01%
201,321
-63,544
-24% -$649K
TREX icon
920
Trex
TREX
$4.4B
$1.81M 0.01%
41,178
+12,563
+44% +$672K
BALY icon
921
Bally's
BALY
$708M
$1.81M 0.01%
91,483
-77,343
-46% -$1.77M
GWRE icon
922
Guidewire Software
GWRE
$13.9B
$1.81M 0.01%
29,324
-18,073
-38% -$1.31M
VOYA icon
923
Voya Financial
VOYA
$8.96B
$1.79M 0.01%
29,592
+2,373
+9% +$145K
PLXS icon
924
Plexus
PLXS
$6.43B
$1.79M 0.01%
20,428
+456
+2% +$40.7K
HPE icon
925
Hewlett Packard
HPE
$58.8B
$1.78M 0.01%
149,027
-21,622
-13% -$294K

Similar funds

Natixis Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Natixis Advisors held 1,542 positions worth $23.6B, up 4% from $22.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Natixis Advisors deployed $1.81B of net new capital in Q3 2022, opening 90 new positions and adding to 818 existing holdings. Its largest new stake was Chemed: 52,930 shares worth $23.1M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Vanguard Total Stock Market ETF, an estimated $31.5M trimmed.

  • Natixis Advisors's largest Q3 2022 buy was Chemed: 52,930 shares worth $23.1M.
  • Natixis Advisors added most to Vanguard FTSE Developed Markets ETF in Q3 2022, an estimated $149M increase.
  • Natixis Advisors's biggest Q3 2022 reduction was Vanguard Total Stock Market ETF, cutting an estimated $31.5M.
  • Natixis Advisors fully exited Domino's in Q3 2022, selling an estimated $4.15M.
  • Natixis Advisors's ten largest holdings make up 15% of its $23.6B portfolio in Q3 2022.
  • Natixis Advisors opened 90 new positions and closed 102 in Q3 2022.
  • Natixis Advisors's portfolio value rose 4% quarter-over-quarter to $23.6B.

Based on Natixis Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.